Excision BioTherapeutics Announces Oral Presentation Highlighting Positive Data from its HBV Program, EBT-107, at the Upcoming ASGCT 2024 Annual Meeting
Oral presentation to highlight proof-of-concept efficacy in reducing HBV biomarkers in serum and intrahepatic HBV in vivo
Excision BioTherapeutics Announces Oral Presentation of Preclinical HSV-1 Keratitis Data at CRISPRMED24 Conference on April 24, 2024
Treatment with EBT-104 resulted in over 90% reduction in viral shedding in HSV-1 Keratitis model
Xendee’s Small Modular Reactor Modeling Shows Significant Carbon Reduction for University of Illinois Urbana-Champaign
The landscape of the electricity grid is rapidly evolving. The University of Illinois Urbana-Champaign (UIUC) and Xendee Corporation (Xendee) have teamed up to lead this transformation.
Anzu Partners Sponsors First U.S. High Tech Venture Days (HTVD)
America and Europe’s finest hard tech startups to pitch at HTVD in Washington, D.C on May 7-8.
Excision BioTherapeutics Announces Oral Presentation of HSV-1 Keratitis Data at CRISPRMED24 Conference on April 24 2024
The presentation will highlight new data from the Company’s emerging preclinical program for herpes simplex virus-1 keratitis (HSV-1 Keratitis).
AM Batteries and Tokyo-based Zeon Partner to Develop Dry Battery Electrode with Novel Binders
Joint agreement created to optimize binders for dry battery electrode manufacturing used for EV batteries, energy storage and beyond
Anzu Partners Promotes Dr. Henk Both to Principal
Henk Both, Ph.D. promoted to Principal for his work leading Anzu Partners’ investments in technologies to enable the clean energy transition
6K Takes Top Honors in Prestigious Awards From Both Forbes and Time Magazine
Recognition Secures Position as Industry Visionary and Market Leader in Sustainable Production of Advanced Materials for Batteries and Additive Manufacturing
BioSkryb Genomics to Present Novel Research on Tumor Heterogeneity at American Association for Cancer Research (AACR) Annual Meeting 2024
BioSkryb will highlight its new automation-ready ResolveDNA® and ResolveOME™ single-cell core kits, and share new breast cancer research and a spotlight presentation
Liquid Instruments brings its Moku test platform to Apple Vision Pro, launching industry-first capabilities for optics research
With Moku for visionOS, users can leverage hand and eye gestures alongside a reconfigurable suite of test instruments to accelerate optics, photonics, and quantum research